# Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging

> **NCT04017104** · — · UNKNOWN · sponsor: **British Columbia Cancer Agency** · enrollment: 60 (estimated)

## Conditions studied

- Neuroendocrine Tumors
- Prostate Cancer
- Prostatic Neoplasms
- Carcinoid Tumor
- Paraganglioma
- Neuroblastoma

## Interventions

- **DIAGNOSTIC_TEST:** 18F-FDG PET/CT
- **DIAGNOSTIC_TEST:** 68Ga-DOTATOC PET/CT
- **DIAGNOSTIC_TEST:** 18F-DCFPyL PET/CT

## Key facts

- **NCT ID:** NCT04017104
- **Lead sponsor:** British Columbia Cancer Agency
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-11-01
- **Primary completion:** 2022-08-01
- **Final completion:** 2024-08-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04017104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04017104, "Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04017104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*